NSABP Members' Area
Password Protected - Access
Limited to NSABP Participating
Institutions Only
NSABP Foundation, Inc.
General NSABP Information
Coalition Comment:
Reconfiguration
IOM Report Group Comment
Contact the NSABP
Pathology Section
Future Meetings
NSABP Newsletters
Media Info on STAR
Employment
Clinical Trials Information
Clinical Trials Overview
Protocol Chart
Never Say Lost
Treatment Trials Information
Protocol B-39
Protocol B-43
Protocol B-47
Prevention Trials Information
Protocol P-1 - BCPT
Protocol P-2 - STAR
Protocol P-5
BreastCancerPrevention.com
Scientific Publications
Related Web Sites
Medical Search Engines
To report problems, ask
questions or make comments,
please send e-mail to:
Webmaster@nsabp.pitt.edu
Protocol B-40
A Randomized Phase III Trial of Neoadjuvant Therapy in Patients with Palpable and Operable Breast Cancer Evaluating the Effect on Pathologic Complete Response (pCR) of Adding Capecitabine or Gemcitabine to Docetaxel when Administered Before AC with or without Bevacizumab and Correlative Science Studies Attempting to Identify Predictors of High Likelihood for pCR with Each of the Regimens
B-40 Contact List
B-40 Schema